National Diabetes Month—epidemic continues despite promising advances

Over the past decades, type 2 diabetes mellitus (T2DM) has risen drastically in prevalence, both within the US and more broadly within high-income countries.

GlobalData Healthcare November 4, 2026

If trends in pharmaceutical advancement continue at a similar pace in the coming decade, widespread treatment could have a tangible impact on the epidemiology of both T2DM and obesity. Credit: Andrzej Rostek via Shutterstock.com.

Unlock FREE Access to Premium Content

Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation.

With a free Clinical Trials Arena profile, you can:

Access exclusive analyst commentary and expert insights
View premium forecasts and data-driven clinical trial intelligence
Stay up to date with clinical trial news, regulatory updates, and industry trends
Receive alerts when new premium content is published